Showing results (1-10 of 212) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2022
Agonizing over the Stimulatory Immune Checkpoint ICOSJerry C Lee, Lawrence FongOncology (Williston Park, N.Y.)|March 17, 2018
Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer VaccinesAmar Patel, Lawrence FongOncology (Williston Park, N.Y.)|June 26, 2018
Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular TherapiesAmar Patel, Lawrence FongProstate Cancer and Prostatic Diseases|April 6, 2021
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancerJacob Stultz, Lawrence FongCurrent Opinion in Molecular Therapeutics|February 9, 2010
Therapeutic vaccines for prostate cancerEdward Cha, Lawrence FongOncoimmunology|April 11, 2018
Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patientsEdward Cha, Lawrence FongJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Immunotherapy for prostate cancer: biology and therapeutic approachesEdward Cha, Lawrence FongThe Journal of Experimental Medicine|August 7, 2025
CD4+ T cell dysfunction in cancerHrishi Venkatesh, Lawrence FongTrends in Cancer|August 6, 2023
CD4+ T cells help myeloid-mediated killing of immune-evasive tumorsKai Wu, Lawrence FongImmunity|December 15, 2021
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolboxDavid Y Oh, Lawrence FongPageof 22